BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Epigenomics AG 

Kleine Präsidentenstraße 1

Berlin    D-10178  Germany
Phone: 49-30-24-34-5-0 Fax: +49-30-24-34-55-55


SEARCH JOBS




Industry
Biotechnology






 Company News
Epigenomics AG Begins Trading On OTCQX® 1/10/2014 9:31:12 AM    More...
Epigenomics AG Signs Licensing And Supply Agreement With Wuhan Kindstar Diagnostics For Epi Prolung In China 1/9/2014 10:41:28 AM    More...
Epigenomics AG Announces FDA Advisory Committee Meeting To Review Epi proColon® 11/27/2013 1:28:30 PM    More...
Epigenomics AG’ Methylated SHOX2 Biomarker Shows Promising Results For Therapy Monitoring Of Lung Cancer Patients 11/20/2013 1:46:47 PM    More...
Epigenomics AG and BioChain Enter Into Broad Strategic Collaboration in China and Investment Into Epigenomics 10/28/2013 9:36:00 AM    More...
Epigenomics AG Signs Joint Commercialization Agreement for Epi proColon® in North America With Polymedco 10/2/2013 9:46:37 AM    More...
Epigenomics AG Secures Financing of Up to EUR 5 Million 8/19/2013 8:57:07 AM    More...
Epigenomics AG Announces H1 2013 and Q2 2013 Financial Results and Reports on Operational Highlights 8/7/2013 9:15:17 AM    More...
Epigenomics AG: U.S. Study Suggests Blood-Based Septin9 CRC Screening Could Save Lives and be Health-Economically Beneficial 7/22/2013 8:38:02 AM    More...
Epigenomics AG Establishes American Depositary Receipt (ADR) Program 7/9/2013 10:44:36 AM    More...
12345678910...